US drugmaker Merck & Co. (MSD) has entered into a global license agreement to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific...
07.02.2018
- Swiss contract development and manufacturing organization (CDMO) Celonic has completed the acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany. Berlin...
01.08.2017
- AstraZeneca has entered into a global collaboration with US drugmaker Merck to develop and commercialize the former’s investigational cancer treatments Lynparza (olaparib) and...
21.04.2017
- US pharmaceutical companies Bristol-Myers Squibb and Apexigen are collaborating to test a combination of their respective drugs to treat patients with advanced solid tumors...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
04.03.2016
- UK companies Centauri Therapeutics and Horizon Discovery have formed a joint venture targeting the rapidly growing immuno-oncology market. The newly formed company Avvinity...
17.02.2016
- Germany’s Merck KGaA has signed a new framework agreement with Israel’s Weizmann Institute of Science, extending their partnership for another three years with the option for...
